Syra Health Corp. Class A Common Stock
SYRA
SYRA was delisted on the 17th of April, 2025.
2 hedge funds and large institutions have $18.8K invested in Syra Health Corp. Class A Common Stock in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.
57% less capital invested
Capital invested by funds: $43.8K → $18.8K (-$25K)
78% less funds holding
Funds holding: 9 → 2 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$29.3K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$4.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$17.9K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.9K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$6.47K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.05K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$3.64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $16.4K | +$29.3K | +150,232 | New |
|
|
XT
2
XTX Topco
George Town,
Cayman Islands
| $2.43K | +$4.36K | +22,301 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| – | -$17.9K | -68,816 | Closed |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| – | -$8.9K | -34,247 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$6.47K | -24,908 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$5.05K | -19,440 | Closed |
|
|
IWM
7
IHT Wealth Management
Chicago,
Illinois
| – | -$3.64K | -14,000 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$1.65K | -6,344 | Closed |
|
9
Citigroup
New York
| – | -$155 | -598 | Closed |
|
10
Barclays
London,
United Kingdom
| – | -$60 | -231 | Closed |
|
11
Bank of America
Charlotte,
North Carolina
| – | -$20 | -77 | Closed |
|
SYRA Hedge Fund Activity: Q2 2025 in Review
2 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q2 2025, worth a combined $18.8K — down 57% from $43.8K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SYRA and 2 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Jane Street, opening a new position worth an estimated $29.3K. The largest seller was Geode Capital Management, exiting entirely with an estimated $17.9K sold.
- 2 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q2 2025, down from 9 in Q1 2025.
- Funds reported $18.8K of Syra Health Corp. Class A Common Stock stock for Q2 2025, down 57% quarter-over-quarter.
- 2 funds opened new Syra Health Corp. Class A Common Stock positions in Q2 2025 and 9 closed out, a net change of -7 holders.
- The largest Syra Health Corp. Class A Common Stock buyer in Q2 2025 was Jane Street, an estimated $29.3K added.
- The largest Syra Health Corp. Class A Common Stock seller in Q2 2025 was Geode Capital Management, an estimated $17.9K sold.
Based on aggregated 13F filings for Q2 2025.